Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, Blinded, Active-Controlled Phase 3 Study of FKB327 vs Humira in Rheumatoid Arthritis Inadequately Controlled on Methotrexate
2014-000109-11Phase 3Completed
- Sponsor
- Fujifilm
- Start
- Oct 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of qletli in rheumatoid arthritis (RA) (2 arms), sponsored by Fujifilm. Primary endpoint: ACR20 response rate. Started Oct 2014; status: completed.
02
Drugs
qletli
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2014-000109-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000109-11.